title: Reconsidering depression as a risk factor for substance use disorder: Insights from rodent models.
abstract: Depression and substance use disorder (SUD) often co-exist and are typically associated with an inaccurate diagnosis, worsened clinical course and poor medication adherence compared to either disorder alone. To date, the biological mechanisms contributing to their strong association remain largely unknown. In this review, we critically analyze preclinical literature on psychostimulant drugs and reconsider the common view that depression is a risk factor for drug use and the development of SUD. Unexpectedly, this investigation led us to conclude that depressive-like states in rodents are associated with a low predisposition to drug intake, at least when considering initial, voluntary and regulated psychostimulant intake. We identified several conceptual gaps and methodological challenges potentially misleading when modeling depression and SUD comorbidity. On the basis of these observations, we propose new innovative perspectives to guide future experiments and advance our knowledge in this field, including the use of newly refined rodent models that better capture hallmarks of depression and SUD.
authors.affiliation: Lyon Neuroscience Research Center, INSERM U1028, CNRS UMR 5292, Team Physiopathology of the neuronal network responsible for the sleep-wake cycle, University Lyon 1, University of Lyon, Lyon, France.
authors.forename: Virginie
authors.initials: V
authors.lastname: Rappeneau
authors.affiliation: Lyon Neuroscience Research Center, INSERM U1028, CNRS UMR 5292, Team Physiopathology of the neuronal network responsible for the sleep-wake cycle, University Lyon 1, University of Lyon, Lyon, France. Electronic address: anne.berod@univ-lyon1.fr.
authors.forename: Anne
authors.initials: A
authors.lastname: Bérod
mesh_terms: D015897:Comorbidity; D003863:Depression; D003866:Depressive Disorder; D006801:Humans; D012307:Risk Factors; D019966:Substance-Related Disorders
keywords: Behavior; Comorbidity; Depression; Psychostimulant; Rodent models; Substance use disorder; Vulnerability